Alan C. Herman, Chief Scientific Officer at Coherus BioSciences, Inc. (CHRS), sold 600 shares at $15.00 ($9K) on 2017-07-05, disclosed to the SEC on 2017-07-07.
Scheduled sale ($9k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| CHRS | SELL | 2017-05-03 | $227K | — | Filing → |
| CHRS | SELL | 2017-04-05 | $470K | — | Filing → |
| CHRS | SELL | 2017-03-03 | $548K | — | Filing → |